Celebrating innovation in the heart of New Orleans! Congratulations to Lowry Curley, PhD, Co-Founder & CSO of @AxoSim, on being honored at the 2024 Downtown NOLA Awards. @dddneworleans #DowntownNOLA
AxoSim, a BioFund portfolio company, is a proud NOBIC tenant and a leader in the biotech industry.
Let's get together at #SfN2024@AxoSim will be showcasing 3 posters at #SfN2024 this year! Stop by Booth #1557 to connect with our team and explore our latest advancements. Be sure to schedule time to meet with our experts https://t.co/jylFsrIRpL
Today we announced Stuart Gibb as our VP of Sales and Marketing. He brings over 20 years of global sales leadership experience, with a demonstrated track record of scaling revenue for high-growth startups and multi-billion-dollar organizations. Full PR: https://t.co/IhcRMxm3lA
AxoSim wishes athletes across the globe a safe, meaningful, and victorious @Olympics.🏅
In celebration of the 2024 games, here's our creative take on the Olympic rings using immunofluorescent neurons of our brain organoids
#fluorescencefriday#microscopy#olympics#paris2024
It was an honor to present yesterday at #ADCTox. If you missed the presentation or want to learn more about AxoSim, stop by our booth to see Megan Terral and Amit Johal.
AxoSim Director of Scientific Operations Megan Terral will speak next week at #ADCTox in Boston. Will we see you there?
💬 High-throughput Functional and Morphological Neurotoxicity Screening in Human NerveSim®
📅 Wednesday, July 24, 2:45 PM EST
We are currently hiring for two new positions: Marketing Manager (Boston) and IT Systems Administrator (Maple Grove). Learn more: https://t.co/phQ0SaXkxn
#hiring#hiringnow#itjobs#sciencejobs
For those who weren't able to attend or would like more time to evaluate the data, we have made our posters from the MPS World Summit available on our website: https://t.co/jrHw7Hxmqi
#mps#mps2024#mpsworldsummit#organoids
Brightfield images of NerveSim® before (DIV43) and after (DIV50) dosing with 100 nM Vincristine. A dose range was performed, yielding quantifiable nerve fiber degeneration to produce an IC50 for the three image analysis metrics.
#microscopymonday#moleculardevices@moldev
AxoSim's microBrain™ organoids can simulate various neurodevelopmental and degenerative diseases. Here, we've grown organoids using iPSCs from a healthy donor (Control) and those of a patient with CDKL5 Deficiency Disorder (CDKL5 KO). 1/2
#revvity#microscopymonday#fromthelab